Mark T. Dransfield

UAB Mentoring Program in COPD Patient Oriented Research

National Heart, Lung, and Blood Institute · K24

Contact PI · $438.7K · University of Alabama at Birmingham

AZD9688: A First in Class Disease Modifying Therapy to Treat Alpha-1 Antitrypsin Deficiency a Genetically Linked Orphan Disease

National Center for Advancing Translational Sciences · UH3

Contact PI · $4.5M · University of Alabama at Birmingham

UAB CF Research and Translation Core Center

National Institute of Diabetes and Digestive and Kidney Diseases · P30

PI · $1.2M · University of Alabama at Birmingham

A Pilot Study of the Effect of the CFTR Potentiator Ivacaftor in COPD (P-TOPIC)

National Heart, Lung, and Blood Institute · R34

PI · $600.1K · University of Alabama at Birmingham

The Multicenter Topic Trial

Principal investigator · Withdrawn · Phase 2

University of Alabama at Birmingham

An Observational Study of Beta-Blocker Use in Patients With COPD and Acute MI

Principal investigator · Completed

University of Minnesota

Alvelestat (MPH966) for the Treatment of ALpha-1 ANTitrypsin Deficiency

Principal investigator · Completed · Phase 2

University of Alabama at Birmingham

Evaluation of COPD Co-Pilot

Principal investigator · Unknown

HGE Health Care Solutions, LLC